Novo Holdings A/S
SEC CIK 1388325 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, Inc. | 10% | 4.18M | — | — | 1 | 2026-05-04 | 2026-05-04 |
| AVLN | Avalyn Pharma Inc. | 10% | 3.33M | $10.00M | — | 2 | 2026-05-01 | 2026-05-01 |
| MPLT | MapLight Therapeutics, Inc. | 10% | 3.69M | $16.20M | — | 2 | 2025-10-28 | 2025-10-28 |
| SPRB | SPRUCE BIOSCIENCES, INC. | 10% | 2.55M | $7.00M | $3.41M | 4 | 2023-02-16 | 2024-03-21 |
| MGX | Metagenomi Therapeutics, Inc. | 10% | 100.0K | $13.03M | — | 2 | 2024-02-09 | 2024-02-13 |
| IRON | Disc Medicine, Inc. | 10% | 1.09M | — | $57.62M | 1 | 2023-06-28 | 2023-06-28 |
| OKUR | OnKure Therapeutics, Inc. | 10% | 3.33M | — | $710.0K | 1 | 2023-06-23 | 2023-06-23 |
| EWTX | Edgewise Therapeutics, Inc. | 10% | 6.07M | $5.00M | — | 1 | 2022-09-14 | 2022-09-14 |
| BOLT | Bolt Biotherapeutics, Inc. | 10% | 3.70M | — | $1.60M | 1 | 2022-07-13 | 2022-07-13 |
Most active insiders at COAG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $55.46M | — |
| 2 | Novo Holdings A/S | 10% | — | — |
| 3 | MARAGANORE JOHN | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-06 16:55 | 2026-05-04 | COAG | Hemab Therapeutics Holdings, Inc. | Novo Holdings A/S | 10% | C - Cnv Deriv | — | +4.18M | 4.18M | New | — |
| D | 2026-05-05 16:15 | 2026-05-01 | AVLN | Avalyn Pharma Inc. | Novo Holdings A/S | 10% | C - Cnv Deriv | — | +3.33M | 3.33M | New | — |
| D | 2026-05-05 16:15 | 2026-05-01 | AVLN | Avalyn Pharma Inc. | Novo Holdings A/S | 10% | P - Purchase | $18.00 | +555.6K | 3.88M | +17% | +$10.00M |
| D | 2025-10-30 | 2025-10-28 | MPLT | MapLight Therapeutics, Inc. | Novo Holdings A/S | 10% | P - Purchase | $17.00 | +952.9K | 3.69M | +35% | +$16.20M |
| D | 2025-10-30 | 2025-10-28 | MPLT | MapLight Therapeutics, Inc. | Novo Holdings A/S | 10% | C - Cnv Deriv | — | +2.73M | 2.73M | New | — |
| 2024-03-25 | 2024-03-21 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% | S - Sale | $0.75 | -465.0K | 2.55M | -15% | -$348.8K | |
| M | 2024-03-20 | 2024-03-18+ | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% | S - Sale | $0.7587 | -1.79M | 3.38M | -35% | -$1.36M |
| 2024-03-18 | 2024-03-14 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% | S - Sale | $0.89 | -1.91M | 4.81M | -28% | -$1.70M | |
| DM | 2024-02-15 | 2024-02-09+ | MGX | Metagenomi Therapeutics, Inc. | Novo Holdings A/S | 10% | P - Purchase | $14.47 | +900.0K | 100.0K | New | +$13.03M |
| D | 2024-02-15 | 2024-02-13 | MGX | Metagenomi Therapeutics, Inc. | Novo Holdings A/S | 10% | C - Cnv Deriv | — | +839.2K | 939.2K | +839% | — |
| 2023-06-28 | 2023-06-28 | IRON | Disc Medicine, Inc. | Novo Holdings A/S | 10% | S - Sale | $46.10 | -1.25M | 1.09M | -53% | -$57.62M | |
| 2023-06-23 | 2023-06-23 | OKUR | OnKure Therapeutics, Inc. | Novo Holdings A/S | 10% | S - Sale | $7.10 | -100.0K | 3.33M | -3% | -$710.0K | |
| D | 2023-02-21 | 2023-02-16 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% | P - Purchase | $3.17 | +2.21M | 6.72M | +49% | +$7.00M |
| 2022-09-16 | 2022-09-14 | EWTX | Edgewise Therapeutics, Inc. | Novo Holdings A/S | 10% | P - Purchase | $10.32 | +484.5K | 6.07M | +9% | +$5.00M | |
| 2022-07-15 | 2022-07-13 | BOLT | Bolt Biotherapeutics, Inc. | Novo Holdings A/S | 10% | S - Sale | $2.00 | -800.0K | 3.70M | -18% | -$1.60M |
Purchase Sale Sale after option exercise All abbreviations